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A B S T R A C T
Management of cervical premalignant lesions starts with abnormal Pap smear. Regular screening of asymptomatic
women (the Pap smear) allows us to diagnose and treat preinvasive lesions before they progress to cervical cancer. There
is a wide variety of ablative and destructive methods used in treatment of cervical premalignant lesions. In this study we
have compared follow-up cytology results in patient groups treated by LLETZ (Large Loop Excision of the Transforma-
tion Zone), Cold Knife Conization (CKC) and Semm’s cold coagulation (Electrocoagulation, ECG) according to CIN on
target biopsy specimen, and definite therapeutic approach according to patient age, parity and lesion grading. The aim
was to evaluate therapeutic success in all three patient groups on the basis of control cytology findings. Normal cytology
findings after treatment were recorded in 43 women in LLETZ group (88%), 22 women in CKC group (73%) and in 22
women from the Semm’s cold coagulation group (73%). The importance of the use of diagnostic and therapeutic guide-
lines and regular follow up is emphasized, bearing in mind primarily the young female population with severe pre-
invasive lesions of uterine cervix. Treating cervical preinvasive lesions offers an excellent opportunity to prevent the oc-
currence of cervical cancer in the large majority of women with abnormal cervical smears.
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Introduction
Cervical cancer has a slow progress, from preinvasive
cervical intraepithelial neoplasia (CIN) to invasive pha-
ses, which means that the disease can be diagnosed while
in the phase of pre-invasive lesion, and treated success-
fully thanks to the regular screening of asymptomatic
women (the Pap smear). In new cytological classification1
cervical lesions have been divided into two groups: High
grade Squamos intraepithelial lesion (HSIL) and Low
grade Squamos intraepithelial lesion (LSIL). CIN I le-
sions belong to LSIL group and CIN II and CIN III be-
long to HSIL group. After the detection of CIN in Pap
smear it is advisable to perform colposcopy. Due to colpo-
scopic finding and previous cytologic abnormality deci-
sion must be made to perform target biopsy and endo-
cervical curettage. If the control Pap smear reveals HSIL
definite treatment is mandatory. There is a wide variety
of ablative and destructive methods used in treatment of
cervical premalignant lesions. For decades, local ablative
techniques have been used to treat cervical premalignant
lesions2. The shared disadvantage of all ablative tech-
niques is the absence of large resection specimens for
histopathological analysis. These techniques proved to
be effective to treat cervical preinvasive lesions2 but have
now largely been replaced by low-morbidity excisional
techniques, the most frequent of which are Cold Knife
Conization (CKC) or LLETZ (Large Loop Excision of the
Transformation Zone). The excisional techniques offer
the advantage of obtaining a large specimen for patholog-
ical assessment to define the disease as well as the com-
pleteness of treatment. Cold-knife conization has been
the traditional procedure for diagnosis and treatment of
cervical dysplasia and early cervical carcinoma not more
13
Received for publication July 24, 2009
than IA2. It is typically performed in a hospital setting
with general or local anesthesia. The concept of the large
loop brought a huge change in the approach of clinicians
to cervical preinvasive lesions. This was described in
1989 by Prendiville et al.3 who published their results of
treatment using a wide, large, thin wire loop. The results
showed a low complication rate and morbidity coupled
with a 98% success rate of treatment. In comparative
studies, LLETZ was found to be as effective or better
treatment for cervical preinvasive lesions than laser4 or
cryotherapy5.
In many clinics, LLETZ has now become the standard
of care for cervical preinvasive lesions.
As it maintains cervical reproductive function, it is
suitable for patients who wish to retain their fertility.
In this study we have compared follow-up cytology re-
sults in patient groups treated by LLETZ, CKC and
Semm’s cold coagulation (Electrocoagulation, ECG) ac-
cording to CIN on target biopsy specimen, and definite
therapeutic approach according to patient age and lesion
grading. To aim was to evaluate therapeutic success in all
three patient groups on the basis of control cytology find-
ings.
Patients and Methods
The study included patients allocated to particular
therapy group according to diagnostic and therapeutic
guidelines for preinvasive lesions of the uterine cervix6,7
during the period from January 1, 1999 till December 31,
2000.
LLETZ was performed in 157, CKC in 42 and Semm’s
cold coagulation in 30 women. The patient mean age was
33.7 years in the LLETZ group, 36.5 years in CKC group
and 30.0 years in the Semm’s cold coagulation group.
LLETZ prevailed in young nulliparous women and CKC
in parous women. Cytology control was available only in
50 out of 157 (32%) women with LLETZ, 30 out of 42
(71%) women with CKC and in all 30 women with
Semm’s cold coagulation.
Results
The distribution of cytology findings according to the
age of the patients prior to LLETZ is shown in Table 1.
HSIL is predominant in age group 21–40 years.
The distribution of biopsy specimen histology accord-
ing to the age of the patients prior to LLETZ is shown in
Table 2. HSIL prevails in 46 out of 50 patients (92%).
The distribution of histology findings according to the
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TABLE 1
CYTOLOGY PRIOR TO LLETZ ACCORDING TO AGE GROUPS
Age ASCUS CIN I CIN II CIN III Total
21–40 2 3 14 24 43
>40 0 1 4 2 7
Total 2 4 18 26 50
LLETZ – Large Loop Excision of the Transformation Zone; CIN
– Cervical Intraepithelial Neoplasia; ASCUS – Atypical Squa-
mos Cell of Undetermined Significance
TABLE 2





CIN I CIN II CIN III Total
21–40 0 3 15 25 43
>40 1 0 3 3 7
Total 1 3 18 28 50
LLETZ – Large Loop Excision of the Transformation Zone;
CIN – Cervical Intraepithelial Neoplasia
TABLE 3




CIN I CIN II CIN III Normal Total
21–40 3 2 9 28 1 43
>40 0 1 2 4 0 7
Total 3 3 11 32 1 50
LLETZ – Large Loop Excision of the Transformation Zone; CIN – Cervical Intraepithelial Neoplasia
TABLE 4
CONTROL CYTOLOGY AFTER LLETZ ACCORDING TO AGE GROUPS
Age ASCUS CIN I CIN II CIN III Normal Total
21–40 1 0 1 1 40 43
>40 2 1 1 0 3 7
Total 3 1 2 1 43 50
LLETZ – Large Loop Excision of the Transformation Zone; CIN – Cervical Intraepithelial Neoplasia; ASCUS – atypical squamos cell of
undetermined significance
age of the patients after LLETZ is shown in Table 3. The
highest prevalence of HSIL can be noticed in age group
21–40. 37 out of 43 women (86%) with HSIL are from
this group.
The distribution of control cytology findings accord-
ing to the age of the patients after LLETZ is shown in Ta-
ble 4. The high percentage of normal cytology findings is
satisfactory; however there are three cases of HSIL after
LLETZ.
The distribution of cytology findings according to the
age of the patients prior to CKC is shown in Table 5.
The distribution of biopsy specimen histology accord-
ing to the age of the patients prior to CKC is shown in Ta-
ble 6. CIN III prevails in age groups 21–40 years. 15 out
of 21 patients with CIN III are in this group (72%).
The distribution of histology findings according to the
age of the patients after CKC is shown in Table 7. CIN III
prevails in age group 21–40 years. Out of 25 patients
with HSIL, 22 of them had CIN III (88%). 4 cases of
chronic endocervicits in age group >40 years suggests
that between biopsy and CKC we should repeat control
cytology and colposcopy and accordingly to those find-
ings decide on further treatment. Although CKC was
preformed in one patient in group >40 years, revealing
CIN I on definitive histology, it was done due to major
colposcopic changes.
The distribution of control cytology findings accord-
ing to the age of the patients after CKC is shown in Table
8.
ECG was performed after cytology screening and col-
poscopy. Following colposcopic criteria had to be met:
¿ Squamocollumnar junction is fully visible
¿ Lesion is clearly marked from surrounding tissue.
ECG was preformed only on those patients who had
biopsy specimen histology no greater than CIN II.
The distribution of control cytology findings accord-
ing to the age of the patients after ECG is shown in Table
9.
In the LLETZ group, 32 out of 50 (64%) histology
specimens revealed CIN III, whereas in the CKC group it
was found in 22 out of 30 (72%) women. Normal cytology
findings after treatment were recorded in 43 women in
LLETZ group (88%), 22 women in CKC group (73%) and
in 22 women from the Semm’s cold coagulation group
(73%).
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TABLE 5
CYTOLOGY PRIOR TO CKC ACCORDING TO AGE GROUPS
Age ASCUS CIN I CIN II CIN III Total
21–40 0 0 1 19 20
>40 0 2 4 4 10
Total 0 2 5 23 30
CKC – Cold Knife Conization; CIN – Cervical Intraepithelial
Neoplasia; ASCUS – atypical squamos cell of undetermined sig-
nificance
TABLE 6






CIN I CIN II CIN III Total
21–40 3 0 2 15 20
>40 0 2 2 6 10
Total 3 2 4 21 30
CKC – Cold Knife Conization; CIN – Cervical Intraepithelial
Neoplasia
TABLE 7




CIN I CIN II CIN III Normal Total
21–40 0 0 3 17 0 20
>40 4 1 0 5 0 10
Total 4 1 3 22 0 30
CKC – Cold Knife Conization; CIN – Cervical Intraepithelial Neoplasia
TABLE 8
CONTROL CYTOLOGY AFTER CKC ACCORDING TO AGE GROUPS
Age ASCUS CIN I CIN II CIN III Normal Total
21–40 3 1 1 1 14 20
>40 2 0 0 0 8 10
Total 5 1 1 1 22 30
CKC – Cold Knife Conization; CIN – Cervical Intraepithelial Neoplasia; ASCUS – Atypical Squamos Cell of Undetermined Significance
Discussion
LLETZ has been demonstrated to be a very effective
way of treating CIN4,8–10. Effectiveness is often regarded
as achieving normal cytology after treatment. Follow-up
schedules vary from 3- to 6-monthly cytology/colposcopy
follow-up assessments, after which the intervals increase
to 6–12 monthly for 5–10 years. The majority of studies
reported abnormal cytology findings in less than 15% of
cases8–11. Factors associated with an increased risk of re-
currence have been identified as involved margins at
LLETZ, grade of disease, age of the patient, HPV status.
Excisional margins may be positive in as many as 48% of
cases12. More concern is caused by involved endocervical
margins as this represents invisible disease. Marginal
ectocervical lesions, in many cases, may have been de-
stroyed with the use of the ball cautery10. Clear margins
have not been found to guarantee normal cytology fol-
low-up, and only some of the patients with involved mar-
gins had abnormal cytology at follow-up8–10.
The histological assessment of completeness of
LLETZ excision cannot be used as a strong predictor of
persistent or recurrent disease.
The grading of CIN as found in the biopsy has some
correlation with risk of recurrence13. Patients with CIN 3
have a much higher risk of residual or recurrent cervical
preinvasive lesions and this may develop over prolonged
follow-up13. Increasing age is identified as an independ-
ent risk factor for persistent or recurrent cervical pre-
neoplasia9. Patients aged 50 years or more with involved
endocervical margins constituted the highest risk group
for recurrent disease9. This should be kept in mind when
arranging follow-up schedules.
Patients with clear margins at CKC have a very low
risk of subsequent abnormal smears of less than 1%14.
Reich et al.15 performed a study of 390 patients with in-
volved margins after CKC, followed for a mean of 19
years clinically and with cytology and colposcopy, and
found that 306 (78%) had no residual or recurrent dis-
ease, 78 (20%) had persistent cervical preinvasive le-
sions, and six (2%) had invasive cervical carcinoma. The
risk of recurrence was higher in cases of involvement of
both endo- and ectocervical margins than when only one
margin was involved. Orbo et al.16 found recurrent dis-
ease in 42 of 371 patients after CKC, but could not detect
a significant correlation between relapse and margins on
univariate analysis. Chao et al.17 found that 279 of 765
(36%) patients treated with CKC had involved endo- or
ectocervical margins. After 3 years of follow-up, the re-
currence rate for CIN was 10.3%. Both HPV positivity at
follow-up and involved margins had a significant associa-
tion with recurrent disease and abnormal follow-up cy-
tology. They proposed that HPV positivity at follow-up
may predict those patients that will undergo recurrence.
Conclusion
The importance of the use of diagnostic and therapeu-
tic guidelines and regular follow up is emphasized, bear-
ing in mind primarily the young female population with
severe preinvasive lesions of uterine cervix. Treating cer-
vical preinvasive lesions offers an excellent opportunity
to prevent the occurrence of cervical cancer in the large
majority of women with abnormal cervical smears.
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TABLE 9
CONTROL CYTOLOGY AFTER ECG IN 30 PATIENTS WITH
PREVIOUS HISTOLOGY FINDING OF CIN II
Cytology
finding
ASCUS CIN I CIN II CIN III Normal
Total 3 3 1 1 22
ECG – Electrocoagulation; CIN – Cervical Intraepithelial Neo-
plasia; ASCUS – Atypical Squamos Cell of Undetermined Signif-
icance
CITOLO[KO PRA]ENJE BOLESNICA S CIN-OM LIJE^ENIH DIJATERMIJSKOM EKSCIZIJOM
(LETZ), KLASI^NOM KONIZACIJOM I HLADNOM KONIZACIJOM PO SEMMU
S A @ E T A K
Lije~enje premalignih lezija vrata maternice zapo~inje sa patolo{kim nalazom Papa testa. Regularni probir asimp-
tomatskih `ena pomo}u Papa testa i drugih dijagnosti~kih postupaka omogu}uje nam da dijagnosticiramo i lije~imo
preinvazivne lezije prije nego {to progrediraju u rak vrata maternice. Postoji {irok izbor ablativnih I destrukcijskih
metoda koje se koriste u lije~enju premalignih lezija vrata maternice. U ovoj studiji uspore|ivali smo kontrolne nalaza
cervikalnih obrisaka (Papa test) kod pacijentica lije~enih dijatermijskom ekscizijom (LLETZ- Large Loop Excision of
the Transformation Zone), klasi~nom konizacijom i hladnom koagulacijom po Semmu po osnovnom kriteriju: na cilja-
noj biopsiji CIN (Cervikalna intraepitelna neoplazija), a primjena definitivnog zahvata s obzirom na dob, paritet i stu-
panj lezije. Terapijski uspjeh u sve tri grupe pacijentica smo odredili na osnovu citolo{kih nalaza. Normalne citolo{ke
nalaze poslije lije~enja su imale 43 `ene u LLETZ grupi (88%), 22 `ene u CKC grupi (73%) i 22 `ene u grupi lije~enoj
hladnom koagulacijom po Semmu (73%). Isti~emo va`nost primjene dijagnosti~ki-terapijskog postupnika te redovitih
kontrola nakon zahvata, prije svega, imaju}i na umu mlade nerotkinje koje trebaju sa~uvati reprodukcijski potencijal.
Lije~enje premalignih promjena na vratu maternice pru`a nam izuzetnu mogu}nost da sprije~imo pojavnost raka vrata
maternice u ve}ine `ena sa patolo{kim obriscima vrata maternice (Papa test).
G. Grubi{i} et al.: Cytologic Follow-up in Patients with CIN after Treatment, Coll. Antropol. 34 (2010) 1: 13–17
17
